Aspen Aerogels (NYSE:ASPN) Sets New 52-Week Low – What’s Next?

Aspen Aerogels, Inc. (NYSE:ASPN)’s stock price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $6.60 and last traded at $6.79, with a volume of 285036 shares traded. The stock had previously closed at $6.93.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Barclays reduced their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. TD Cowen raised shares of Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, March 11th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Finally, Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Price Performance

The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $578.93 million, a P/E ratio of 44.10 and a beta of 2.28. The firm has a 50 day moving average of $9.61 and a 200-day moving average of $15.32.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, equities research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Several hedge funds have recently bought and sold shares of the business. Abbot Financial Management Inc. raised its position in Aspen Aerogels by 3.9% during the 4th quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company’s stock valued at $359,000 after purchasing an additional 1,146 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of Aspen Aerogels by 5.3% during the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after buying an additional 1,483 shares during the period. Invesco Ltd. raised its holdings in shares of Aspen Aerogels by 3.5% in the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock valued at $604,000 after acquiring an additional 1,724 shares in the last quarter. Greenwood Capital Associates LLC lifted its stake in Aspen Aerogels by 5.0% in the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock worth $439,000 after acquiring an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC lifted its stake in Aspen Aerogels by 6.3% in the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock worth $425,000 after acquiring an additional 2,118 shares during the period. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.